At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effectiveness of Smoking Cessation in Prediabetic Smokers
In Brief
A clinical study evaluating Varenicline for tobacco smoking cessation and Individualized counseling about both smoking cessation and weight control techniques for Diabetes Mellitus and 2 related conditions. Active but no longer recruiting, targeting 589 participants across 1 site.
Detailed Summary
Existing literature investigating the impact of smoking cessation on new-onset diabetes mellitus (DM) risk is conflicting. Combing the need for smoking cessation and body weight self-management to prevent the progression of prediabetes stage into DM, with the public implementation of the second-generation cessation program, we aimed to study the effectiveness of the Fight Tobacco and Stay Fit (FIT2) program aiming at promoting smoking cessation and restricting post-cessation weight gain (PCWG) together in prediabetic smokers regarding long-term glycemic and DM-related health outcomes.
Study Details
Timeline
Interventions
The 16-week varenicline course conforms to real-practice government regulations in Taiwan.
The FIT2 program also offers behavior coaching in diet and physical activity to restrict post-cessation weight gain, which is not covered in conventional smoking cessation services.